Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.962 | 0.972 | 1.00000 | 1.00000 | |
RegionR2 | 7.028 | 0.972 | 0.07777 | 0.34122 | |
RegionR3 | 0.841 | 0.972 | 0.85394 | 1.00000 | |
RegionR4 | -2.037 | 0.972 | 0.99906 | 1.00000 | |
RegionR5 | -0.803 | 0.972 | 0.96395 | 1.00000 | |
RegionR6 | 2.654 | 0.972 | 0.34181 | 0.92878 | |
RegionR7 | -1.433 | 0.972 | 1.00000 | 1.00000 | |
RegionR8 | -1.289 | 0.972 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 3.743 | 0.972 | 0.99982 | 1.00000 | |
RegenerationR2 | -5.012 | 0.972 | 0.18158 | 0.62467 | |
RegenerationR3 | -0.48 | 0.972 | 0.67925 | 0.94012 | |
RegenerationR4 | 0.054 | 0.972 | 0.77744 | 0.97963 | |
RegenerationR5 | 2.071 | 0.972 | 0.89208 | 1.00000 | |
RegenerationR6 | -2.333 | 0.972 | 0.40218 | 0.73901 | |
RegenerationBL | -0.125 | 0.972 | 0.99978 | 1.00000 | |
RegenerationTP | 4.292 | 0.972 | 0.57916 | 0.94919 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 3 | 1.000 | 1.000 | - | - | 1.000 | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
2. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
1.934 | 0.944 | 0.990 | - | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
3. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
1.927 | 0.937 | 0.990 | - | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
4. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 1.925 | 0.938 | 0.987 | - | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
5. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
1.916 | 0.924 | 0.992 | - | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
6. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.911 | 0.924 | 0.987 | - | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
7. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.906 | 0.921 | 0.985 | - | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
8. | MligTC455_15974 | 179 | 3.73 | Mlig455_046153, Mlig455_046238 | Neo: - Age: - Region-enriched R2: 9.367/0.02495 |
1.905 | 0.924 | - | - | - | 0.981 | - | Mlig455_046153 {REF} {Length: 345} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.0]} {RNA1310_79109} {RNA815_46493} Mlig455_046238 {REF} {Length: 211} {NoTransDecoderORF} {RNA1310_79109} {RNA815_46493} |
|
9. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.9 | 0.924 | 0.976 | - | - | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
10. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
1.898 | 0.928 | 0.970 | - | - | - | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
11. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.893 | 0.901 | 0.992 | - | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
12. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 1.883 | 0.954 | 0.929 | - | - | - | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
13. | MligTC455_14059 | 24 | 0.5 | Mlig455_037086 | Neo: - Age: - Region-enriched R2: 8.935/0.00338 |
1.876 | 0.924 | 0.952 | - | - | - | - | Mlig455_037086 {REF} {Length: 1622} {Pfam: Galactosyltransferase [PF01762.23, score=18.6]} {RNA1310_57689} {RNA815_57743} | |
14. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 1.871 | 0.890 | 0.981 | - | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
15. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.867 | 0.883 | 0.984 | - | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
16. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
1.85 | 0.862 | 0.988 | - | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
17. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 1.84 | 0.858 | 0.982 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
18. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 1.837 | 0.975 | 0.862 | - | - | - | - | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
19. | MligTC455_20105 | 19 | 0.39 | Mlig455_031770 | Neo: - Age: - |
GEM | 1.81 | 0.955 | 0.855 | - | - | - | - | Mlig455_031770 {REF} {Length: 3348} {Pfam: Ras family [PF00071.24, score=56.4]} {Human: ENSG00000164949, GEM, GTP binding protein overexpressed in skeletal muscle, [Score=84.7, Expect=4e-18]; ENSG00000166592, RRAD, RRAD, Ras related glycolysis inhibitor and calcium channel regulator, [Score=82.0, Expect=5e-17]} {Mouse: ENSMUSG00000028214, Gem, GTP binding protein (gene overexpressed in skeletal muscle), [Score=84.3, Expect=5e-18]; ENSMUSG00000000359, Rem1, rad and gem related GTP binding protein 1, [Score=81.3, Expect=6e-17]} {Dmel: FBgn0085419, Rgk2, Rad, Gem/Kir family member 2, [Score=107, Expect=3e-25]} {Celegans: WBGene00021027, W04C9.5, [RH, Score=67.4, Expect=3e-12]} {Smed: dd_Smed_v6_11010_0_1, dd_Smed_v6_11010_0_1, [Score=147, Expect=9e-41]} {RNA1310_124922} |
20. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1.804 | 0.811 | 0.993 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
21. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
1.8 | 0.958 | 0.842 | - | - | - | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
22. | MligTC455_20122 | 48 | 1 | Mlig455_004561, Mlig455_064755 | Neo: - Age: - |
1.791 | 0.967 | 0.824 | - | - | - | - | Mlig455_004561 {REF} {Length: 665} {RNA1310_57601} Mlig455_064755 {REF} {Length: 650} {TRANSSPLICED} {RNA1310_57601} |
|
23. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.777 | 0.785 | 0.992 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
24. | MligTC455_51154 | 45 | 0.94 | Mlig455_045899 | Neo: - Age: - |
CPED1 | 1.747 | 0.957 | 0.790 | - | - | - | - | Mlig455_045899 {REF} {Length: 3530} {Human: ENSG00000106034, CPED1, cadherin like and PC-esterase domain containing 1, [RH, Score=178, Expect=2e-47]} {Mouse: ENSMUSG00000062980, Cped1, cadherin-like and PC-esterase domain containing 1, [RH, Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_14757_0_1, dd_Smed_v6_14757_0_1, [RH, Score=188, Expect=3e-53]} {RNA1509_12903} {RNA1310_19899.1} {RNA815_44464} |
25. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.732 | 0.778 | 0.954 | - | - | - | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
26. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.716 | 0.965 | 0.751 | - | - | - | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
27. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 1.711 | 0.975 | 0.736 | - | - | - | - | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
28. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 1.709 | 0.717 | 0.992 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
29. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 1.703 | 0.715 | 0.988 | - | - | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
30. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
1.683 | 0.717 | 0.966 | - | - | - | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
31. | MligTC455_02205 | 14 | 0.29 | Mlig455_027460 | Neo: - Age: - |
WDR17 | 0.997 | - | - | - | - | 0.997 | - | Mlig455_027460 {REF} {Length: 4333} {Pfam: WD domain, G-beta repeat [PF00400.34, score=104.7]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=57.5]} {Human: ENSG00000150627, WDR17, WD repeat domain 17, [Score=842, Expect=0.0]} {Mouse: ENSMUSG00000039375, Wdr17, WD repeat domain 17, [Score=858, Expect=0.0]} {Dmel: FBgn0263933, ebi, [Score=84.7, Expect=3e-16]} {Celegans: WBGene00004767, sel-10, F-box/WD repeat-containing protein sel-10, [Score=88.6, Expect=1e-17]} {Smed: dd_Smed_v6_2866_0_1, dd_Smed_v6_2866_0_1, [Score=80.9, Expect=3e-16]} {RNA1310_124405} {RNA815_31576} |
32. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
0.995 | - | 0.995 | - | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
33. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.993 | - | 0.993 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
34. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
0.992 | - | 0.992 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
35. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
36. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
37. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
38. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
39. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
40. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 0.992 | - | 0.992 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
41. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.992 | - | 0.992 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
42. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
43. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
0.992 | - | 0.992 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
44. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.991 | - | 0.991 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
45. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.99 | - | 0.990 | - | - | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
46. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.989 | - | 0.989 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
47. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.989 | - | 0.989 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
48. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.989 | - | 0.989 | - | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
49. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
0.988 | - | 0.988 | - | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
50. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 0.987 | 0.987 | - | - | - | - | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
51. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.985 | - | 0.985 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
52. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
53. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
0.984 | - | 0.984 | - | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
54. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.981 | - | 0.981 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
55. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
0.98 | - | 0.980 | - | - | - | - | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
56. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.979 | - | 0.979 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
57. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.979 | - | 0.979 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
58. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 0.979 | - | 0.979 | - | - | - | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
59. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.979 | - | 0.979 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
60. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
0.978 | - | 0.978 | - | - | - | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
61. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
0.977 | 0.977 | - | - | - | - | - | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
62. | MligTC455_51276 | 83 | 1.74 | Mlig455_014757, Mlig455_014817 | Neo: - Age: Down-Up-Down |
CTGF | 0.977 | 0.977 | - | - | - | - | - | Mlig455_014757 {REF} {Length: 2922} {Pfam: CCN3 Nov like TSP1 domain [PF19035.2, score=54.0]; Insulin-like growth factor binding protein [PF00219.20, score=36.3]; von Willebrand factor type C domain [PF00093.20, score=24.9]} {Human: ENSG00000118523, CTGF, connective tissue growth factor, [RH, Score=191, Expect=6e-57]} {Mouse: ENSMUSG00000019997, Ctgf, connective tissue growth factor, [RH, Score=182, Expect=1e-53]; ENSMUSG00000005124, Wisp1, WNT1 inducible signaling pathway protein 1, [RH, Score=180, Expect=9e-53]; ENSMUSG00000028195, Cyr61, cysteine rich protein 61, [RH, Score=179, Expect=2e-52]} {Dmel: FBgn0052183, Ccn, [RH, Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_18465_0_1, dd_Smed_v6_18465_0_1, [RH, Score=152, Expect=2e-42]} {RNA1310_28561} {RNA815_18173} Mlig455_014817 {REF} {Length: 2230} {Pfam: CCN3 Nov like TSP1 domain [PF19035.2, score=54.1]; Insulin-like growth factor binding protein [PF00219.20, score=36.3]; von Willebrand factor type C domain [PF00093.20, score=24.9]} {Human: ENSG00000118523, CTGF, connective tissue growth factor, [RH, Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000019997, Ctgf, connective tissue growth factor, [RH, Score=180, Expect=4e-53]; ENSMUSG00000005124, Wisp1, WNT1 inducible signaling pathway protein 1, [RH, Score=178, Expect=3e-52]; ENSMUSG00000028195, Cyr61, cysteine rich protein 61, [RH, Score=176, Expect=2e-51]} {Dmel: FBgn0052183, Ccn, [RH, Score=74.7, Expect=2e-14]} {Smed: dd_Smed_v6_18465_0_1, dd_Smed_v6_18465_0_1, [RH, Score=150, Expect=5e-42]} {RNA1310_28561} {RNA815_18173} |
63. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 0.976 | - | 0.976 | - | - | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
64. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.976 | - | 0.976 | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
65. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
0.976 | - | 0.976 | - | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
66. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 0.975 | - | 0.975 | - | - | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
67. | MligTC455_15747 | 66 | 1.38 | Mlig455_044205 | Neo: - Age: Down-Up-Up |
0.975 | - | - | - | - | 0.975 | - | Mlig455_044205 {REF} {Length: 935} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_28325.2} {RNA815_29746} | |
68. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
0.975 | 0.975 | - | - | - | - | - | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
69. | MligTC455_13789 | 45 | 0.93 | Mlig455_015853 | Neo: Irradiation Age: Down-Up-Down |
SYT7 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_015853 {REF} {Length: 2964} {Pfam: C2 domain [PF00168.32, score=37.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [Score=57.8, Expect=1e-08]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [Score=53.9, Expect=1e-07]} {Smed: dd_Smed_v6_20523_0_1, dd_Smed_v6_20523_0_1, [Score=82.0, Expect=3e-17]} {RNA1509_40740} {RNA1310_34364} {RNA815_36355} |
70. | MligTC455_18935 | 141 | 2.93 | Mlig455_012123, Mlig455_029004 | Neo: - Age: logFC(26M/2M)=-1.032 |
IRF1 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_012123 {REF} {Length: 1962} {Pfam: Interferon regulatory factor transcription factor [PF00605.19, score=61.2]} {Human: ENSG00000125347, IRF1, interferon regulatory factor 1, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000018899, Irf1, interferon regulatory factor 1, [Score=58.5, Expect=4e-09]; ENSMUSG00000031627, Irf2, interferon regulatory factor 2, [Score=55.8, Expect=3e-08]} {RNA1509_44213} {RNA1310_27978.1} {RNA815_17421} Mlig455_029004 {REF} {Length: 1330} {Pfam: Interferon regulatory factor transcription factor [PF00605.19, score=59.6]} {Human: ENSG00000125347, IRF1, interferon regulatory factor 1, [Score=57.4, Expect=4e-09]; ENSG00000168310, IRF2, interferon regulatory factor 2, [Score=55.1, Expect=3e-08]} {Mouse: ENSMUSG00000018899, Irf1, interferon regulatory factor 1, [Score=56.6, Expect=6e-09]; ENSMUSG00000031627, Irf2, interferon regulatory factor 2, [Score=54.7, Expect=2e-08]} {RNA1310_27978.1} {RNA815_17421} |
71. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.974 | - | 0.974 | - | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
72. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 0.974 | 0.974 | - | - | - | - | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
73. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
0.973 | - | 0.973 | - | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
74. | MligTC455_36566 | 40 | 0.83 | Mlig455_053263 | Neo: - Age: - Region-enriched R2: 4.823/0.01830 |
0.973 | - | 0.973 | - | - | - | - | Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871} | |
75. | MligTC455_42364 | 9 | 0.2 | Mlig455_007252 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_007252 {REF} {Length: 523} {RNA1509_2515} {RNA1310_11307} {RNA815_3258.1} | |
76. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.973 | - | 0.973 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
77. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
0.972 | 0.972 | - | - | - | - | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
78. | MligTC455_21693 | 48 | 1 | Mlig455_024307, Mlig455_024362, Mlig455_024476 | Neo: - Age: - |
AHR | 0.972 | 0.972 | - | - | - | - | - | Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588} Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588} Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588} |
79. | MligTC455_22257 | 24 | 0.49 | Mlig455_002961 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_002961 {REF} {Length: 1429} {NoTransDecoderORF} {RNA1509_19236} {RNA1310_28041.2} {RNA815_50832.1} | |
80. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
0.972 | 0.972 | - | - | - | - | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
81. | MligTC455_05659 | 9 | 0.19 | Mlig455_000779 | Neo: - Age: - |
0.971 | - | 0.971 | - | - | - | - | Mlig455_000779 {REF} {Length: 525} {RNA1509_14736} {RNA1310_6965} {RNA815_41421} | |
82. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
0.971 | 0.971 | - | - | - | - | - | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
83. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
0.97 | - | 0.970 | - | - | - | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
84. | MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
0.97 | - | 0.970 | - | - | - | - | Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} | |
85. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
0.969 | 0.969 | - | - | - | - | - | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
86. | MligTC455_26230 | 55 | 1.15 | Mlig455_006974 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_006974 {REF} {Length: 3113} {Pfam: Rel homology DNA-binding domain [PF00554.24, score=54.1]} {RNA1509_2844} {RNA1310_68356} {RNA815_32175} | |
87. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 0.969 | - | 0.969 | - | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
88. | MligTC455_36618 | 545 | 11.35 | Mlig455_020301, Mlig455_020358 | Neo: - Age: logFC(26M/2M)=-0.435 Region-enriched R2: 3.072/0.00097 |
SLC7A6 | 0.969 | 0.969 | - | - | - | - | - | Mlig455_020301 {REF} {Length: 4137} {Pfam: Amino acid permease [PF13520.8, score=183.8]; Amino acid permease [PF00324.23, score=95.7]} {Human: ENSG00000103064, SLC7A6, solute carrier family 7 member 6, [RH, Score=421, Expect=7e-143]; ENSG00000155465, SLC7A7, solute carrier family 7 member 7, [RH, Score=412, Expect=1e-139]; ENSG00000103257, SLC7A5, solute carrier family 7 member 5, [RH, Score=410, Expect=1e-138]} {Mouse: ENSMUSG00000031904, Slc7a6, solute carrier family 7 (cationic amino acid transporter, y+ system), member 6, [RH, Score=419, Expect=2e-142]; ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [RH, Score=413, Expect=3e-140]; ENSMUSG00000000958, Slc7a7, solute carrier family 7 (cationic amino acid transporter, y+ system), member 7, [RH, Score=410, Expect=4e-139]} {Dmel: FBgn0039844, CG1607, [RH, Score=467, Expect=2e-161]} {Celegans: WBGene00000002, aat-1, Amino Acid Transporter, [RH, Score=431, Expect=1e-147]} {Smed: dd_Smed_v6_2179_0_1, dd_Smed_v6_2179_0_1, [RH, Score=498, Expect=5e-174]} {RNA1509_26498} {RNA1310_9422, RNA1509_26498} {RNA1509_26498, RNA815_5493} Mlig455_020358 {REF} {Length: 3120} {Pfam: Amino acid permease [PF13520.8, score=147.1]; Amino acid permease [PF00324.23, score=74.6]} {Human: ENSG00000103064, SLC7A6, solute carrier family 7 member 6, [Score=346, Expect=6e-115]; ENSG00000155465, SLC7A7, solute carrier family 7 member 7, [Score=340, Expect=2e-112]} {Mouse: ENSMUSG00000031904, Slc7a6, solute carrier family 7 (cationic amino acid transporter, y+ system), member 6, [Score=340, Expect=9e-113]; ENSMUSG00000000958, Slc7a7, solute carrier family 7 (cationic amino acid transporter, y+ system), member 7, [Score=335, Expect=7e-111]; ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [Score=325, Expect=6e-107]} {Dmel: FBgn0039844, CG1607, [Score=390, Expect=1e-132]} {Celegans: WBGene00000002, aat-1, Amino Acid Transporter, [Score=353, Expect=2e-118]} {Smed: dd_Smed_v6_7207_0_1, dd_Smed_v6_7207_0_1, [Score=416, Expect=3e-143]} {RNA1509_56112} {RNA1310_9422, RNA1509_56112} {RNA1509_56112, RNA815_5493} |
89. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 0.969 | 0.969 | - | - | - | - | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
90. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
0.969 | - | 0.969 | - | - | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
91. | MligTC455_06514 | 12 | 0.26 | Mlig455_001637 | Neo: - Age: - |
0.967 | 0.967 | - | - | - | - | - | Mlig455_001637 {REF} {Length: 928} {NoTransDecoderORF} {RNA1310_113137} | |
92. | MligTC455_10753 | 13 | 0.27 | Mlig455_036562 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_036562 {REF} {Length: 1200} | |
93. | MligTC455_13094 | 121 | 2.52 | Mlig455_005442, Mlig455_005513 | Neo: - Age: Up-Up-Down |
0.967 | 0.967 | - | - | - | - | - | Mlig455_005442 {REF} {Length: 3816} {Smed: dd_Smed_v6_15433_0_1, dd_Smed_v6_15433_0_1, [Score=141, Expect=1e-34]} {RNA1509_41201} {RNA1310_51044} {RNA815_32534} Mlig455_005513 {REF} {Length: 685} {NoTransDecoderORF} {RNA1310_56412} {RNA815_32534} |
|
94. | MligTC455_15099 | 26 | 0.54 | Mlig455_057991, Mlig455_058185 | Neo: - Age: - Region-enriched R4: 8.074/0.00255 |
PCDH9 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_057991 {REF} {Length: 5180} {Pfam: Cadherin domain [PF00028.19, score=245.9]; Cadherin-like [PF16184.7, score=32.1]; Cadherin-like [PF08266.14, score=31.0]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=277, Expect=2e-77]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=277, Expect=4e-77]} {Dmel: FBgn0001075, ft, fat, [Score=211, Expect=5e-55]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=171, Expect=7e-43]} {Smed: dd_Smed_v6_16566_0_2, dd_Smed_v6_16566_0_2, [Score=317, Expect=1e-92]} {RNA1509_38512} {RNA1310_81930} Mlig455_058185 {REF} {Length: 2168} {RNA1310_95463.1} |
95. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
0.967 | 0.967 | - | - | - | - | - | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
96. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
0.967 | - | 0.967 | - | - | - | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
97. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
0.967 | 0.967 | - | - | - | - | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
98. | MligTC455_19329 | 90 | 1.88 | Mlig455_068578 | Neo: - Age: - Region-enriched R2: 3.988/0.02701 |
CHAT | 0.966 | 0.966 | - | - | - | - | - | Mlig455_068578 {REF} {Length: 3661} {TRANSSPLICED} {Pfam: Choline/Carnitine o-acyltransferase [PF00755.22, score=556.7]} {Human: ENSG00000070748, CHAT, choline O-acetyltransferase, [RH, Score=519, Expect=2e-177]} {Mouse: ENSMUSG00000021919, Chat, choline acetyltransferase, [RH, Score=520, Expect=7e-178]} {Dmel: FBgn0000303, ChAT, Choline acetyltransferase, [RH, Score=488, Expect=1e-164]} {Celegans: WBGene00000481, cha-1, Choline O-acetyltransferase, [RH, Score=363, Expect=2e-117]} {Smed: dd_Smed_v6_6208_0_1, dd_Smed_v6_6208_0_1, [RH, Score=601, Expect=0.0]} {RNA1509_36058} {RNA1310_3092, RNA1509_36058} {RNA1509_36058, RNA815_2435.1} |
99. | MligTC455_20757 | 286 | 5.96 | Mlig455_005125, Mlig455_005185 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_005125 {REF} {Length: 1290} {RNA1310_29676.2} {RNA815_31533} Mlig455_005185 {REF} {Length: 1357} {RNA1310_29676.1} {RNA815_31533} |
|
100. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
0.966 | 0.966 | - | - | - | - | - | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} |